CH-Lausanne-CHUV

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials
• Myelodysplastic syndromes2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Stichting Hemato-Oncologie voor Volwassenen Nederland2 trials

Running trials

• Active, not recruiting

  A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

  NCT04027309· Phase 3· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source

• Active, not recruiting

  Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients

  NCT04097470· Phase 2· Stichting Hemato-Oncologie voor Volwassenen Nederland· Source